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Abstract
Objective
We estimated HIV-free infant survival and mother-to-child HIV transmission (MTCT) rates in
Zimbabwe, some of the first community-based estimates from a UNAIDS priority country.
Methods
In 2012 we surveyed mother-infant pairs residing in the catchment areas of 157 health facili-
ties randomly selected from 5 of 10 provinces in Zimbabwe. Enrolled infants were born
9–18 months before the survey. We collected questionnaires, blood samples for HIV test-
ing, and verbal autopsies for deceased mothers/infants. Estimates were assessed among i)
all HIV-exposed infants, as part of an impact evaluation of Option A of the 2010WHO guide-
lines (rolled out in Zimbabwe in 2011), and ii) the subgroup of infants unexposed to Option
A. We compared province-level MTCT rates measured among women in the community
with MTCT rates measured using program monitoring data from facilities serving those
communities.
Findings
Among 8568 women with known HIV serostatus, 1107 (12.9%) were HIV-infected. Among
all HIV-exposed infants, HIV-free infant survival was 90.9% (95% confidence interval
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(CI): 88.7–92.7) and MTCT was 8.8% (95% CI: 6.9–11.1). Sixty-six percent of HIV-exposed
infants were still breastfeeding. Among the 762 infants born before Option A was imple-
mented, 90.5% (95% CI: 88.1–92.5) were alive and HIV-uninfected at 9–18 months of age,
and 9.1% (95%CI: 7.1–11.7) were HIV-infected. In four provinces, the community-based
MTCT rate was higher than the facility-based MTCT rate. In Harare, the community and
facility-based rates were 6.0% and 9.1%, respectively.
Conclusion
By 2012 Zimbabwe had made substantial progress towards the elimination of MTCT. Our
HIV-free infant survival and MTCT estimates capture HIV transmissions during pregnancy,
delivery and breastfeeding regardless of whether or not mothers accessed health services.
These estimates also provide a baseline against which to measure the impact of Option A
guidelines (and subsequently Option B+).
Introduction
Pediatric HIV/AIDS remains a major global public health issue, with 330,000 children newly
infected with HIV in 2011, 90% of whom lived in Sub-Saharan Africa.[1] In 2011 UNAIDS
launched a global plan to eliminate new pediatric HIV infections by 2015, which focused on
twenty-two priority countries where 90% of the world’s HIV-infected pregnant women reside.
[2] To this end, the World Health Organization (WHO) revised their 2006 guidelines for the
elimination of mother-to-child HIV transmission (eMTCT) in developing countries. Specifi-
cally, in 2010 WHO recommended that HIV-infected pregnant women eligible for antiretrovi-
ral therapy (ART) receive lifelong therapy, while ART-ineligible women receive one of two
antiretroviral (ARV) prophylactic regimens (Options A or B) to prevent MTCT during preg-
nancy and breastfeeding.[3] Compared to the earlier guidelines, the 2010 guidelines recom-
mended lifelong ART for a larger group of HIV-infected women (i.e., CD4350 or clinical
stage 3–4 vs. CD4200), and that ARV prophylaxis be provided earlier in the pregnancy
(i.e., starting at 14 weeks instead of 28). In addition, for the first time, ARVs to prevent MTCT
during breastfeeding were recommended in settings where breastfeeding is the safest feeding
option. In 2013, WHO updated their guidelines again, recommending that all pregnant
women, regardless of clinical stage, receive ART at a minimum during pregnancy and breast-
feeding (Option B) or ideally lifelong (Option B+).[4]
Although many developing countries have adopted the 2010 guidelines or are beginning to
adopt the 2013 WHO-recommended regimens,[5] little is known about their population-level
effectiveness (regimen efficacy combined with adherence and program coverage).[6] Recogniz-
ing that facility-based estimates of impact may overestimate the true effect of eMTCT regimens
as they only include mothers who accessed health services, WHO has urged countries to con-
duct population-level impact assessments of their eMTCT programs, with rates of MTCT and
HIV-free infant survival, ideally measured at 18 months, used as the main outcomes to deter-
mine impact.[7] HIV-free infant survival is considered the gold standard, as it accounts for
deaths prevented and infant infections at birth and during breastfeeding.[8]
Zimbabwe, a UNAIDS priority country, has an estimated 1.4 million people living with
HIV infection. Modeling studies conducted between 2009 and 2011 estimated that MTCT
ranged between 17% and 30%.[9–12] In 2011, Zimbabwe’s Ministry of Health and Child Care
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(MoHCC) implemented Option A of the 2010 WHO guidelines. Specifically, MoHCC rolled
out this program in 1344 of the existing 1,560 health facilities in the country between August
and December 2011, distributed point-of-care CD4 testing machines for determination of ART
eligibility, and facilitated community mobilization to increase entry and retention in the
PMTCT cascade; UNAIDS commended the Zimbabwe MoHCC for this successful country-
wide implementation.[13] Zimbabwe began rollout of Option B+ in November 2013.
Well in advance of the 2013 WHO guidelines and working with the MoHCC, we designed
an evaluation consisting of serial cross-sectional community-based surveys to determine the
impact of Option A on HIV-free infant survival and MTCT at 9–18 months postpartum in
Zimbabwe. Here we present estimates of HIV-free infant survival and MTCT based on our
baseline survey, conducted in May-September 2012. We calculated these estimates among all
HIV-exposed infants, irrespective of potential exposure to Option A. We also assessed these
rates in the subgroup of infants who were not exposed to Option A. Lastly, we compared prov-
ince-level MTCT rates based on the community survey with MTCT rates based on monitoring
and evaluation data from facilities in the same provinces, to verify the assumption underlying
WHO recommendations that facility-based estimates of impact are likely to overestimate the
effectiveness of eMTCT regimens.
Methods
We conducted a cross-sectional survey of mother-infant pairs selected in two stages. First, we
randomly selected 157 health facilities from the 699 facilities offering antenatal care in five of
Zimbabwe’s ten provinces. Second, we identified 21,205 eligible mother-infant pairs living in
the catchment areas of these 157 facilities, selected a pre-determined fraction of them and
invited them to participate in the survey. Infants born 9–18 months prior to the survey and
their mothers/ caregivers were eligible for the survey. Overall, 9,087 mother-infant pairs partic-
ipated in the 2012 survey. We conducted questionnaires with mothers/ caregivers, verbal
autopsies regarding the deceased mothers/infants, and collected maternal and infant blood
samples for HIV testing. In addition, we administered a short questionnaire to head nurses in
the 157 health facilities. See Fig 1 for a brief summary of the study design. Below we discuss
and explain in detail the study population, sampling strategy, data collection methods, labora-
tory procedures, data analysis, and the measures for the protection of human subjects.
Study population
The study population consisted of infants born 9–18 months before the survey and their moth-
ers or caregivers (16 years old). The infants’ age range allowed us to capture HIV transmis-
sions occurring during pregnancy, delivery, and breastfeeding.[3] Given the high maternal
mortality associated with HIV infection[14] and the high mortality among HIV-infected
infants,[15] we included deceased mothers and infants. Overall, 9,087 mother-infant pairs par-
ticipated in the survey; 68 infants and 55 mothers were deceased at the time of the survey. Fig 2
explains in detail the samples used in the analyses conducted for this paper.
Sampling strategy
Resources precluded sampling the entire country. Hence, our target population was mother-
infant pairs residing in five of Zimbabwe’s ten provinces (Harare, Mashonaland West, Masho-
naland Central, Manicaland, Matabeleland South), selected to include three of the four largest
cities in Zimbabwe, rural communities with high and low HIV prevalence, representation of
both major ethnic groups in Zimbabwe (Shona, Ndebele), and areas where detailed monitoring
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and evaluation data were being collected. Harare is the capital and an urban metropolis,
whereas the other four provinces include both urban and rural populations.
First, we randomly selected 157 of 699 health facilities offering eMTCT services in these
provinces and administered a questionnaire with head nurses to capture the services delivered
at that facility and the timing of Option A rollout. We selected as primary sampling units the
catchment areas (CAs) of these facilities. (In this study we used the health facility catchment
areas, which are geographical areas defined by the MoHCC. CAs are defined by boundaries of
the administrative ward(s), which are subdivisions of districts.) CAs were randomly sampled
proportionate to the number of facilities in their district. In each sampled CA, we identified
all eligible infants (i.e. infants born 9–18 months before the survey and their16 years old
Fig 1. Survey timeline, sampling strategy, data collectionmethods and outcomesmeasured for the 2012 survey of the impact evaluation of
Zimbabwe’s Accelerated PMTCT program. * In each catchment area, we used one of the following sampling fractions (so that we enroll an average of 50
mother-infant pairs per catchment area, which was one of the assumptions of our power calculations): 1) 1 in 4 eligible mother-infant pairs if the catchment
area had over 300 eligible infants, 2) 1 in 2 infants if the catchment area had 150 to 300 eligible infants, or 3) all the mother-infant pairs if the catchment area
had fewer than 150 eligible infants.
doi:10.1371/journal.pone.0134571.g001
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Fig 2. Samples of mother-infant pairs used to calculate three estimates of HIV-free infant survival at 9–18months, Zimbabwe, 2012. The flowchart
summarizes what samples were used to estimate HIV-free infant survival at 9–18 months. The overall estimate of HIV-free infant survival (‘estimate A’) was
assessed among the ‘HIV-exposed infants’ sample (i.e., 1,081 pairs with HIV-infected mothers and infants either deceased or with available HIV status). The
pre-Option A estimates of HIV-free infant survival (‘estimates B1 and B2’) were assessed among subsets of the ‘HIV-exposed infants’ sample, after excluding
the infants who were exposed to Option A activities. We measured exposure to Option A activities in two ways: 1) according to the facility closest to the
infant’s residence at the time of the survey, and 2) according to the facility where antenatal care (ANC) was received. These pre-Option A samples of infants
were used to assess HIV-free infant survival using two definitions of exposure: ‘by residence’ (‘estimate B1’) and ‘by ANC facility’ (‘estimate B2’).
doi:10.1371/journal.pone.0134571.g002
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mothers or caregivers) and sampled a known fraction of these infants with the objective of
enrolling 50 infants per CA. Specifically, in each CA we used one of the following sampling
fractions: 1) 1 in 4 eligible mother-infant pairs if the CA was estimated to have over 300 eligible
infants, 2) 1 in 2 infants if the CA was estimated to have 150 to 300 eligible infants, or 3) all the
mother-infant pairs if the CA was estimated to have fewer than 150 eligible infants. Sample size
was calculated to adequately power the impact evaluation.
Infants born in the previous two years were identified based on information pooled from: 1)
community health workers (CHWs) and 2) immunization registers from selected facilities and
neighboring facilities (to identify women residing in sampled facilities who accessed services at
adjacent facilities). Further, mothers identified using (1) and (2) were asked to identify other
eligible infants in their neighborhood. This three-pronged approach efficiently identified eligi-
ble participants without screening all the households in the selected CAs and captured mother-
infant pairs who received care outside their area of residence.
Data collection
Participating mothers/caregivers completed anonymous interviewer-administered question-
naires that captured the mother’s demographic characteristics, experience with antenatal and
postnatal care, delivery, ART and ARV prophylaxis for the eligible child. When participants
had patient-held medical records in their possession (i.e., infant health card, maternal health
card), interviewers collected information on HIV status and treatment recorded on these docu-
ments. In addition, all living biological mothers and infants provided dried blood spot samples
(DBS) for HIV testing, following written informed consent. If the biological mother of an
eligible infant was deceased, we interviewed the caregiver to assess whether HIV/AIDS was the
probable cause of the maternal death. Similarly, if the eligible infant was deceased at the time of
the survey, we interviewed the biological mother to assess the baby’s likely cause of death. To
this end, we used verbal autopsy questionnaires developed by the WHO and adapted them for
our population.
Laboratory procedures
Blood samples were air-dried onto filter papers and stored at room temperature until trans-
ported biweekly to the National Microbiology Reference Laboratory in Harare. Maternal
samples were tested for HIV-1 antibody using AniLabsytems EIA kit (AniLabsystems Ltd,
OyToilette 3, FIN-01720) with all positive specimens confirmed using Enzygnost Anti-HIV
1/2 Plus ELISA and discrepant results resolved by Western Blot. We tested the samples of the
infants born to HIV-positive mothers as well as the infants born to mothers whose sample was
unavailable; infant samples were tested for HIV with DNA polymerase chain reaction (Roche
Amplicor HIV-1 DNA Test 1.5). External quality assurance was conducted on 7% of samples.
Data analysis
Primary outcomes. We estimated two outcomes:
1. HIV-free infant survival (proportion of infants born to HIV-infected mothers who were
alive and HIV-uninfected at 9–18 months of age): The denominator (number of HIV-
infected mothers) was assessed based on either i) laboratory-confirmed HIV test results
(99.4%), ii) verbal autopsy data (for deceased mothers, 0.3%), or iii) information recorded
on maternal health cards (for deceased or unavailable mothers, 0.3%). To classify deaths as
due to AIDS from verbal autopsy data, we used an algorithm validated in Zimbabwe.[16]
The numerator (number of living HIV-uninfected infants) was assessed based on i)
HIV-Free Infant Survival in Zimbabwe
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laboratory-confirmed HIV test results (97.7%), ii) information recorded on infant health
cards (1.8%), and iii) reports of infants’ deaths (0.5%).
2. MTCT (proportion of infants born to HIV-infected mothers who were HIV-infected at
9–18 months of age) uses the same denominator as HIV-free infant survival. The numerator
(number of infants HIV-infected or deceased related to HIV/AIDS) was assessed based on
i) laboratory-confirmed HIV test results (98.1%), ii) verbal autopsy data (for deceased
infants, 1.3%), and iii) information recorded on infant health cards (0.6%). A Zimbabwean
pediatrician (HAM) examined the infant verbal autopsy data and rated the likelihood of
each death being HIV-related (on a 5-point scale ranging between ‘very unlikely’ and ‘very
likely’) based on: gestational age at delivery, birth weight, infant age at death, symptoms
indicative of common opportunistic infections in children, along with the chronicity of
their illness and factors that affect likelihood of MTCT. ‘Likely’ and ‘very likely’ cases were
classified as infant HIV/AIDS-related deaths.
Assessment of exposure to Option A. We defined exposure to Option A in two ways.
First, mother-infant pairs were considered exposed to Option A activities if infants were born
afterOption A guidelines were implemented in the facility closest to their place of residence at
the time of the survey. (Note that the impact evaluation was designed based on this definition
of exposure to Option A, as the national PMTCT program was implemented at the facility
level). Although the order in which communities were surveyed was timed to maximize the
likelihood that all enrolled infants were born before program rollout, we identified some infants
born after Option A was implemented in the closest facility. The timing of Option A rollout
was unavailable for two sampled facilities.
Second, mother-infant pairs were considered exposed to Option A activities if infants were
born after Option A guidelines were implemented in the facility where their mothers reported
to have received antenatal care. This alternative definition of exposure to Option A acknowl-
edges that not everyone sought care at the facility closest to their residence and captures mobil-
ity in seeking care. Although more precise than the definition of exposure to Option A based
on the nearest facility, assessment of the facility where the mother received antenatal care was
only possible for the subset of women who attended prenatal care at the 155 facilities in our
sample where we could verify the exact timing of Option A rollout; we used this second defini-
tion of exposure to Option A in sensitivity analyses (see below).
Statistical analysis. We present descriptive statistics of facility- and individual-level char-
acteristics and the primary outcomes. For each primary outcome (defined above), we provide
three sets of estimates (see Fig 2 for details on the samples used to generate each set of esti-
mates). First, we assessed overall, community-based estimates (‘estimate A’) among the sample
of infants born to HIV-infected mothers, irrespective of potential exposure to Option A. Sec-
ond, we restricted these estimates to infants born before Option A was implemented in the
facility closest to their residence at the time of the survey (‘estimate B1’). Third, we limited the
estimates to infants born before Option A was rolled out in the facility where they reportedly
received antenatal care (‘estimate B2’), to examine the sensitivity of the B1 estimates to poten-
tial mobility during pregnancy. In other words, for estimates B1 and B2 we excluded infants
exposed to Option A activities.
We also compared the community-based estimate of MTCT (‘estimate A’) measured with
the community serosurvey to the MTCT rate measured with facility-based monitoring and
evaluation data collected by the National Health Information Unit of the MOHCC. We
limited this comparison to MOHCC estimates from facilities serving the communities included
in survey, and examined possible differences in province-level estimates by source of data. The
facility-based data represent the results of all routine HIV tests conducted in 2012 among
HIV-Free Infant Survival in Zimbabwe
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HIV-exposed infants up to 18 months (most of these infants were<4 months old). Each health
facility sends the infant blood samples to a central collection point, where they are batched
with other specimens and sent weekly to the National Microbiology Reference Laboratory to
be tested for HIV with DNA polymerase chain reaction.
All the analyses of the community-based survey data were conducted using the software
package STATA version 12 (StataCorp, Texas). The data were weighted to account for the
two-stage stratified cluster design and survey non-response; thus, we estimated the above-men-
tioned key outcomes using STATA svy commands.
Human subjects protection
The protocol was approved by the Medical Research Council of Zimbabwe and the ethics com-
mittees of University of California, Berkeley and University College London. All participants
provided written informed consent prior to participation and were compensated for their time
with a gift worth $5. The study includes infants who provided dried blood spots samples for
HIV testing; collection of the dried blood spots samples was only conducted after written
informed consent from their mothers/ caregivers was obtained. In addition, some of the moth-
ers were 16 to 21 year old; according to the Medical Research Council of Zimbabwe, these
mothers are emancipated minors capable of providing informed consent for themselves and
their children’s participation in a research study. Participants could retrieve their anonymous
HIV test results at the local facility up to 3 months following the survey, using a card with bar-
code numbers.
Results
We sampled a diverse group of 157 facilities (Table 1). Most facilities offered key eMTCT ser-
vices on-site, including antenatal care (n = 156), HIV testing (n = 156), maternal (n = 152) and
infant ARV prophylaxis (n = 154), postnatal care (n = 157) and immunizations (n = 156), with
delivery (n = 139) and on-site CD4 testing (n = 96) being the least available services.
Of the 9184 eligible mother-infant pairs selected from the sampled CAs, we enrolled 9087
pairs (98.9% response rate) who participated in at least one survey component (questionnaire,
maternal DBS, or infant DBS). Overall, 8568 mothers had an HIV result and 1107 (12.9%, 95%
confidence interval (CI): 12.2–13.6) were HIV-infected. Twenty-seven infants (2.5% of HIV-
exposed infants) were sampled from catchment areas where we could not assess exposure to
Option A. The appendix illustrates the overlap between the samples of mother-infant pairs
used to estimate B1 (n = 762) and B2 (n = 529).
Table 2 provides the socio-demographic profile of HIV-infected mothers (sample used
to generate estimate A), and of HIV-infected mothers with infants unexposed to Option A.
Because the profiles of Option A-unexposed mothers assessed using definition B1 (i.e., whether
Option A guidelines were implemented in the facility closest to the residence at the time of the
survey) are statistically indistinguishable from Option A-unexposed mothers using definition
B2 (whether Option A guidelines were implemented in the facility where they reportedly
received antenatal care), here we present the profile of the B1 sample only (as that is the base-
line of our impact evaluation). The socio-demographic profiles of the two samples of HIV-
infected mothers were very similar. HIV-infected mothers were mostly married (81%) and had
multiple births (86%). Most of them lived in large households (79% with4 members) that
reported having experienced some household food insecurity (61%). Only 29% of mothers had
finished high school and 23% were employed.
Fig 3 presents the estimates of HIV-free infant survival and Fig 4 presents MTCT at 9–18
months of age. Among the sample of infants born to HIV-infected mothers, irrespective of
HIV-Free Infant Survival in Zimbabwe
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Table 1. Characteristics of sampled health facilities in five provinces, Zimbabwe, 2012.
Number of health
facilities
Frequency distribution of
health facilities
(n = 157) (%, out of 100%)
Type of facility
Central / provincial / district hospital 6 3.8
Mission / rural health hospital 15 9.6
Local authority 3 1.9
Private hospital 2 1.3
Rural health clinic 96 61.2
Polyclinic 9 5.7
Satellite clinic 4 2.6
Other (mostly clinics) 22 14.0
Estimated population in health facility
catchment area
<5000 39 24.8
5000–9999 60 38.2
10000–14999 33 21.0
15000+ 17 10.8
Don't know 8 5.1
Number of rooms in facility
Mean (standard deviation) 145 9.0 (10.3)
Staff members in facility (except village
health workers)
Mean (standard deviation) 153 14.1 (56.2)
Number of village health workers / health
promoters
Mean (standard deviation) 150 7.3 (7.2)
Link with communities (multiple choice
question)
No link to the community 1 0.6
Community health nurse 23 14.7
Village health worker 129 82.2
Home based care cadre 10 6.4
Outreach teams 5 3.2
Environmental health officer 16 10.2
Other 40 25.5
Services offered during the month prior to
the survey
Antenatal care 156 99.4
HIV testing for pregnant women 156 99.4
Maternal ARV prophylaxis 152 96.8
Infant ARV prophylaxis 154 98.1
Labor and delivery 139 88.5
Postnatal care 157 100.0
Immunizations for infants 156 99.4
CD4 testing on-site 96 61.2
doi:10.1371/journal.pone.0134571.t001
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Table 2. Socio-demographic characteristics of mother-infant pairs enrolled in the baseline survey, for specific subpopulations (unweighted N and
%), Zimbabwe, 2012.
‘HIV-exposed infants’ and their
mothers, irrespective of whether
they were exposed to Option A or
not (sample A)
Infants ‘unexposed to Option A
activities based on their residence’
and their mothers (sample B1)
N % N %
(n = 1075)* (n = 759)*
Mothers’ age
16–20 years 67 6.3 51 6.8
21–25 years 264 24.8 184 24.6
26–30 years 323 30.4 229 30.6
31–35 years 268 25.2 183 24.4
36+ years 141 13.3 102 13.6
Mothers’ ethnicity
Shona 757 71.2 556 74.2
Ndebele 163 15.3 97 13.0
Other 143 13.5 96 12.8
Mothers’ marital status
Married 863 81.2 596 79.6
Previously married 143 13.5 110 14.7
Never married 57 5.4 43 5.7
Mothers’ parity
1 birth 150 14.2 116 15.5
2 births 269 25.4 188 25.2
3 births 265 25.0 185 24.8
4+ births 376 35.5 258 34.5
Mothers’ education
Primary or less 424 39.9 294 39.3
Form 1–3 337 31.7 231 30.8
Form 4 293 27.6 217 29.0
Form 5+ 9 0.9 7 0.9
Household size
1–3 people 223 21.0 170 22.7
4 people 245 23.1 160 21.4
5 people 233 21.9 167 22.3
6 people 152 14.3 102 13.6
7+ people 210 19.8 150 20.0
Household food insecurity
Severe insecurity 303 28.5 205 27.4
Some insecurity 343 32.3 255 34.1
Food secure 417 39.2 289 38.6
Mothers employed 246 23.3 172 23.2
Infants alive or deceased
Deceased 19 1.8 13 1.7
Alive 1050 98.2 739 98.3
Among alive infants (n = 1050) (n = 739)
Infants’ age
9–10 months 235 22.4 65 8.8
(Continued)
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potential exposure to Option A, HIV-free infant survival was 90.9% (95% CI: 88.7–92.7) and
MTCT was 8.8% (95% CI: 6.9–11.1) (estimates A). Among the infants born before Option A
was implemented in the facility closest to their residence at the time of the survey, 90.5% (95%
CI: 88.1–92.5) of infants born to HIV-infected mothers were alive and HIV-uninfected at 9–18
months of age; 9.1% (95% CI: 7.1–11.7) of them were HIV-positive (estimates B1). Sensitivity
analyses among the sample of infants born before Option A was rolled out in the facility where
Table 2. (Continued)
‘HIV-exposed infants’ and their
mothers, irrespective of whether
they were exposed to Option A or
not (sample A)
Infants ‘unexposed to Option A
activities based on their residence’
and their mothers (sample B1)
N % N %
(n = 1075)* (n = 759)*
11–12 months 238 22.7 148 20.0
13–14 months 222 21.1 195 26.4
15–16 months 196 18.7 179 24.2
17–18 months 159 15.1 152 20.6
* Sample size differs from the one listed in Fig 2, as i) this table only examines data regarding biological mothers and ii) some of the biological mothers
included in the estimate of HIV-free infant survival did not answer the questionnaire.
doi:10.1371/journal.pone.0134571.t002
Fig 3. HIV-free infant survival at 9–18months of age in five provinces in Zimbabwe, 2012. The figure
shows estimates and 95% confidence intervals adjusted for the survey design. Weighted frequencies are
shown on the x-axis. The sample size (unweighted) differs from that listed on Fig 4 due to missing data
regarding the infants’ status for a few mother-infant pairs.
doi:10.1371/journal.pone.0134571.g003
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their mothers reportedly received antenatal care yielded an estimate of HIV-free infant survival
of 89.8% (95% CI: 86.8–92.2) and MTCT of 10.1% (95% CI: 7.7–13.1).
Fig 5 compares province-level MTCT estimates from the community-based survey (esti-
mate A) and national monitoring and evaluation data from facilities serving those communi-
ties. Overall, the MTCT rate based on the program data is slightly lower than based on the
community-based data (7.1% vs. 8.8%, p = 0.063). In four of the five provinces examined, the
community-level estimates of MTCT are higher than the facility-based estimates; the opposite
is the case in Harare.
Discussion
We estimate that in 2012, 90.9% of HIV-exposed infants in five provinces in Zimbabwe were
alive and HIV-uninfected at 9–18 months of age, and 8.8% were HIV-infected. Our two esti-
mates of HIV-free infant survival and MTCT prior to the implementation of Option A were
very similar to each other and comparable to the overall rates (irrespective of exposure to
Option A). These estimates, among the first community-based estimates from a UNAIDS pri-
ority country, capture HIV transmissions during pregnancy, delivery and the first 9–18 months
of breastfeeding among HIV-exposed mother-infant pairs regardless of whether they attended
eMTCT services. Although much lower than previous estimates,[9–12] as of 2012 there was
nevertheless a substantial gap between this transmission rate and the eMTCT goal of<5%
MTCT.
We compared the MTCT estimates from our community-based survey with facility-based
estimates based on data from Zimbabwe’s National Health Information System. With the
exception of facilities in Harare, community-based estimates in each province were higher
Fig 4. Mother-to-child HIV transmission rate at 9–18 months of age in five provinces in Zimbabwe,
2012. The figure shows estimates and 95% confidence intervals adjusted for the survey design. Weighted
frequencies are shown on the x-axis. The sample size (unweighted) differs from that listed on Fig 3 due to
missing data regarding the infants’ status for a fewmother-infant pairs.
doi:10.1371/journal.pone.0134571.g004
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than facility-based estimates from the same province. Notably, the community MTCT rate is
from the serosurvey conducted in May-September 2012 among babies aged 9 to 18 months,
while the facility MTCT rate is from early infant testing conducted in January-December 2012
among babies mostly under 4 months. Thus, the higher MTCT rates we observe in four of the
five provinces may be due in part to the fact that the community serosurvey captures both
early and late MTCT transmissions. In addition, mothers who were not retained in the eMTCT
cascade may be less likely to return to a facility for early infant testing and might be expected to
have higher rates of MTCT. Data from four provinces support the assumption that commu-
nity-based estimates of MTCT are likely to be more representative than facility-based estimates
based on early infant testing. However, in Harare, program data suggest a higher MTCT rate
than the community survey, possibly because many high-risk women come in from rural areas
to give birth in Harare to receive high quality healthcare in case of complications. Further,
although many women who live in Harare go to their parents’ home in rural areas for the birth
and postpartum period, it is likely that women who know they are at high-risk will be less likely
to travel in order to access the better quality healthcare available in Harare. As such higher risk
women may be overrepresented in Harare facilities, while the community survey likely includes
both low-risk and high-risk women.
Unlike our survey, most eMTCT effectiveness studies have been facility-based. Facility-
based designs have significant drawbacks. Loss to follow-up (LTFU) and incomplete and
inconsistent record keeping are major concerns in analyses of existing program data.[6] Cohort
studies among women recruited from facilities are also sensitive to LTFU and bias due to selec-
tion into the cohort or to the care and follow-up they receive.[6] Surveys conducted among
mother-infant pairs attending childhood immunizations only provide MTCT estimates of
early transmission and do not account for breastfeeding-related transmission.
In contrast, community-based serosurveys such as ours [17,18] can estimate MTCT and
HIV-free infant survival post-breastfeeding, and capture information about mothers not
accessing eMTCT services. There are examples of similar designs. Serial community-based
survey data showed that a pilot program implementing Option B in four Zambian facilities
Fig 5. Mother-to-child HIV transmission rate by province, estimated by the community survey and by
Zimbabwe’s National Health Information System using facility-basedmonitoring and evaluation data.
The community survey was conducted in May-September 2012 and enrolled babies aged 9 to 18 months,
while the facility-based data consists of early infant testing conducted in January-December 2012 among
babies mostly <4 months.
doi:10.1371/journal.pone.0134571.g005
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increased HIV-free survival at 24 months (from 66% at baseline to 89% post-intervention,
adjusted hazard ratio 0.52).[17] The four-country PEARL study, which is currently underway,
is also using a community-based design to assess eMTCT effectiveness; in 2007–2009 this
study estimated HIV-free survival at 24 months to be 73% in Cameroon, 78% in South Africa,
83% in Zambia, and 84% in Cote D’Ivoire.[18]
Over the past decade there have been substantial reductions in MTCT at 6 weeks as a result
of eMTCT interventions; rates fell in Malawi (26.6% in 2004, 15.5% in 2006,[19] 4.1% in 2009–
2011,[20] 8.5% in 2011[21]) and in South Africa (20% in 2004–2005,[22] 10% in 2009,[23]
3.5% in 2010,[24] 2.7% in 2011[25]). However, HIV-free infant survival provides more robust
evidence of programmatic effectiveness than MTCT rates. HIV-free infant survival ranges
from 66% at 18–20 months in Malawi (2009 facility-based cohort data)[26] to 91.9% at 9–24
months in Rwanda (2009 nationwide cross-sectional survey prior to Option B rollout).[27]
Our estimates, based on community-based survey data, suggest that Zimbabwe has made con-
siderable progress towards elimination of MTCT, with 91% of infants born to HIV-infected
mothers remaining alive and HIV-uninfected at 9–18 months of age even before rollout of
Option A.
Our community-based findings will serve as baseline estimates for the impact evaluation
of Option A and Option B+ in Zimbabwe. These data will be triangulated with facility-based
data from early infant testing (as we have done in this paper) as well as an ongoing impact
assessment study, which prospectively follows mother-infant pairs identified at the 6–8 week
immunization visit. Together, these studies will provide the MOHCC with a comprehensive
understanding of the population-level effectiveness of Options A and B+, and answers to oper-
ational research questions. Although global standards have moved towards Option B+, its
implementation and costs are not without challenges; hence understanding the population-
level effectiveness of Option A remains informative.
Our study is subject to limitations. Although our estimates account for transmissions
occurring during the first 9–18 months of breastfeeding, 66% of HIV-exposed infants were still
breastfeeding at the time of the survey (median duration of breastfeeding is 17.8 months in
Zimbabwe[14]). Thus, HIV-free survival at 24 months (at the end of breastfeeding) could be
lower, and MTCT might be higher. Nonetheless, estimates restricted to all HIV-exposed
infants no longer breastfeeding at the time of the survey were comparable: 91.9% (95% CI:
86.8–95.1) HIV-free infant survival and 8.1% (95% CI: 4.9–13.2) MTCT (data not shown). Fur-
ther, despite our efforts to enroll all eligible mother-infant pairs and rely on verbal autopsy
data, infant deaths may have been underreported.
Moreover, although some sampled clinics did not offer the entire cascade of eMTCT ser-
vices, because of the complexity of matching the services offered at the clinic level with the
needs of each mother-infant pair, we did not take this into account when attributing exposure
to Option A. Finally, data were only collected in five of ten provinces, although these were
widely dispersed across the country and included major cities. Nevertheless, our findings are
consistent with national-level data from the 2010–2011 ZHDS that similarly estimated that
12% of pregnant women were HIV-infected.[14]
In sum, we found that by 2012 when Option A was implemented in Zimbabwe, the country
had made substantial progress towards the elimination of MTCT. Our HIV-free infant survival
and MTCT estimates compliment the facility-based findings of early transmission to capture
HIV transmissions during pregnancy, delivery and the first 9–18 months of breastfeeding
regardless of whether or not mothers accessed health services. Our findings inform the progress
and remaining challenges of Zimbabwe’s national eMTCT program.
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